What your crown is actually made of: the material tier problem in dental tourism

Disclosure. Dr. Maloney has no commercial relationship with any dental materials manufacturer, laboratory, or supply chain entity. She did not receive payment, travel, accommodation, equipment, or any other consideration in connection with this piece. Standing disclosures are at /disclosures/. Last reviewed: 2026-06-03.

When a patient receives a crown at a dental tourist clinic and is told it is a “high-quality zirconia crown,” that sentence is technically true and practically almost meaningless. Zirconia, the ceramic material marketed for its strength and tooth-like opacity, exists in a range extending from precisely characterised, rigorously tested, branded formulations from established manufacturers with published clinical survival data, to anonymous white blocks milled from generic batches in offshore facilities whose lot traceability ends at the shipping container.

Both of those produce something a dentist can glue to your tooth. Only one of them has a published survival curve you can read.

The price differential between the high and low ends of the zirconia supply chain is substantial. So is the survival differential. The gap between them is invisible at the seating appointment because a freshly polished zirconia crown looks the same at both ends of the tier. It looks the same at two years. The divergence begins around three to five years, when crowns using generic materials and substandard luting cements start debonding, chipping, or showing the early signs of marginal breakdown that a well-made crown should not show for ten to fifteen years.

This piece is about the material tier, why it exists, and how to find out, before you agree to treatment, whether what you are being quoted is at the high end or the low end.

The crown supply chain

A crown is not a procedure performed entirely at the chairside. It is a manufactured item, produced in a dental laboratory, that the clinician then cements to a prepared tooth. The quality of that manufactured item depends on the entire supply chain from the decision about which material to use through to the laboratory technician’s skill and the cement chosen for bonding.

That supply chain has several points at which cost reduction is possible, and a clinic optimising for margin in a price-competitive tourism market has an incentive to reduce cost at each of them.

The material block. Monolithic zirconia crowns are milled from pre-fabricated blocks of zirconia ceramic in a CAD/CAM process. The blocks vary. Named-manufacturer blocks from companies such as Ivoclar, 3M, or Kuraray have controlled crystalline microstructure, documented flexural strength, published colour-stability data, and batch traceability that allows a technician to match a replacement crown years later. Generic blocks from offshore suppliers may meet basic ISO minimum thresholds while using a microstructure and processing protocol whose long-term performance is not published in peer-reviewed literature. From the outside, a crown milled from each looks identical. The survival curve is where they diverge.

The laboratory. A crown is only as good as the laboratory that made it. A laboratory with trained and experienced technicians, calibrated milling equipment, controlled oven temperatures for sintering, and a quality-management system that catches out-of-tolerance margins before the crown is shipped produces a different product from a high-volume mill with lower quality controls. The BDJ’s 2025 aftermath review describes clinicians attempting to remediate crowns from returned tourists who cannot identify which laboratory made the restoration, what material was used, or whether the cementation protocol was compatible with the material. Without that information, re-cementation or replacement requires guessing, and guessing wrong can debond a sound crown or bond an already-failing one more firmly.

The cement. The luting cement that bonds a crown to a prepared tooth has a direct effect on crown retention. Resin cements with documented adhesive performance to specific zirconia surfaces produce higher bond strengths and longer clinical retention than generic zinc phosphate cements, particularly on preparations with limited retention height, which describes most aggressively prepared cosmetic cases. A clinic that mills zirconia crowns and cements them with a generic non-adhesive cement has made a decision about cost that the patient will eventually experience as a crown that debonds three years after it should have been secure for fifteen.

The emergence profile and fit. The accuracy of the crown margin, the fit at the crown-tooth interface, and the emergence profile at the gingival margin are determined by the laboratory’s skill and the quality of the impression or digital scan supplied to it. A poorly fitting margin is a bacterial ingress point. Bacterial accumulation at the margin initiates secondary caries under the crown, which is invisible until the crown is removed, at which point what was a marginal caries lesion may have progressed to involvement of the pulp. Corrective work on a crown with failed margins is not a clean redo. It is root canal treatment followed by a new crown.

The implant system problem

The same tier structure applies to implant fixtures themselves, and the consequences of being at the lower end of the implant tier are more serious than the consequences of being at the lower end of the crown tier.

A dental implant is a titanium fixture whose surface characteristics, thread geometry, and coronal design are engineered to achieve osseointegration and resist long-term peri-implant bone loss. The major established systems have five- to fifteen-year survival data from prospective multi-centre trials, published in peer-reviewed implantology journals, with reported complication rates and failure modes that clinicians can evaluate and quote to patients.

Generic implant systems, manufactured to meet minimum regulatory thresholds in jurisdictions with lighter-touch oversight, may have limited published clinical follow-up. They may use surface coatings whose long-term peri-implant tissue response is not well characterised. Their component parts, the implant body, the abutment, and the prosthetic screw, may not be manufactured to the tolerances that prevent micromovement at the implant-abutment interface, which is a known contributor to crestal bone loss in the first years after loading.

A clinic using a named, well-documented implant system with published ten-year survival data is making a material choice that the patient can, in principle, investigate. A clinic using a system with no published trial data is making a material choice that the patient has no way to evaluate, and the clinic has a reason for the choice that is almost always price.

The Euronews 2022 investigation into Turkish dental tourism included testimony from patients whose crown and implant work failed within one to two years of placement. The consistent pattern in failed cases was not that the procedures were performed incorrectly. It was that the materials failed earlier than a patient who spent £15,000 to £25,000 in a domestic clinic would expect. The price difference was real. Some of it was lower labour costs, lower overheads, and currency effects. Some of it was materials.

What survival data actually shows

The peer-reviewed survival literature on crowns and implants provides benchmarks against which any clinical claim about longevity can be evaluated.

For porcelain-fused-to-metal and zirconia-based fixed dental prostheses, Pjetursson and colleagues’ 2015 systematic review of tooth-supported fixed prostheses reported five-year survival rates above 93% for metal-ceramic and above 90% for all-ceramic single crowns using named systems in the included trials. The ten-year survival rates in the same review were lower, and the complication rates (chipping, debonding, secondary caries) accumulated over time. The key point is that these figures come from studies using documented materials, documented techniques, and documented follow-up. They are not extrapolable to unnamed materials used in undocumented settings.

For veneers, the Layton and Walton 2007 study, a 16-year prospective study of 304 porcelain veneers, reported survival rates consistent with long-term dental prosthesis data for the specific material and bonding system used. The tissue-conservation piece veneers, crowns, and composite bonding uses this study as one reference point for the comparative argument.

The survival data published in the literature is, in almost every case, data from accredited clinical settings using named materials from documented suppliers. It does not represent the performance of the cheapest available material under the least-supervised production conditions. When a dental tourism clinic cites “survival rates” without specifying which system, which study, and what the patient population in that study looked like, the citation is doing cosmetic work on the marketing page rather than informative work on the clinical one.

The traceability problem

When a crown fails, the clinician attempting remediation needs to know several things: what material the crown is made of, what cement was used to bond it, and what implant system it is seated on if it is implant-retained. Without these, re-cementation is guesswork, replacement crown fabrication cannot be material-matched, and removal requires either trial and error or imaging.

Dental Protection’s 2023 guidance for UK clinicians managing the fallout of dental tourism describes this traceability failure as one of the most consistent features of returned cases. The patient arrives with a failing restoration, no clinical records, no laboratory documentation, and often no recollection of what brand of material she was told was used. “High-quality zirconia” is not a specification. It is a marketing descriptor.

The consequence for the domestic clinician is that every decision about how to manage the failing restoration is made on incomplete information. The consequence for the patient is that the clinician’s uncertainty about materials increases both the time required for the remediation and the likelihood that the chosen approach has to be revised.

A patient who returns from overseas treatment with full clinical records, a laboratory prescription, the implant brand and lot number, a digital scan of the final restorations, and the material specification for every crown is in a position to be treated efficiently and safely by a domestic clinician. Most returning patients have none of these.

How to ask the right questions before treatment

This is not an unsolvable problem from the patient’s side. The questions are specific and the answers are either verifiable or revealing.

Which implant system? The brand name should be a name that appears in peer-reviewed literature. Nobel Biocare, Straumann, Dentsply Sirona, Zimmer Biomet, and a handful of others have extensive published clinical trial data. If the answer is a brand name you cannot find in PubMed literature or in the published list of systems used in clinical trials you can read, ask why. “We use a Korean system, very high quality” is not an answer. It is an invitation to stop asking.

Which zirconia block and which laboratory? The material brand should be nameable. The laboratory should be identifiable, ideally with a verifiable address and a quality certification (ISO 9001 for dental laboratory practice is standard in accredited settings). A clinic that cannot answer this question is either using an unnamed generic material or is not involved in the laboratory supply chain in a way that allows transparency.

Which luting cement? For adhesively retained zirconia, the cement type and whether the zirconia surface will be conditioned before cementation (using primers such as MDP phosphate monomer to promote adhesion) determines the long-term bond strength. A clinic cementing zirconia without a documented adhesive protocol is not using the current evidence base.

Will you provide written clinical records and a material specification sheet before I fly home? This is the one question whose answer tells you everything about the clinic’s accountability posture. A clinic that will not provide this documentation is a clinic that does not intend to be traceable when things go wrong. That is a piece of information worth having before you pay the deposit.

The price and what it actually covers

A full-arch crown case for £4,000 in Antalya, compared to £18,000 in a domestic specialist practice, represents a genuine cost difference. Some of that difference is labour costs. Some is currency effects and lower overhead. Some is materials.

In a well-run Turkish clinic using named-manufacturer zirconia, accredited laboratory services, documented cementation protocols, and full clinical records, the material quality gap to a domestic specialist practice may be small. The price difference may reflect labour and overhead rather than materials.

In a high-volume cosmetic clinic whose price point requires cutting costs at every chainlink, the material quality gap is real and the patient has no visibility into it. She sees the finished crown. She does not see the block it was milled from, the laboratory it came from, or the cement used to seat it. The gap will make itself known on its own schedule.

The overtreatment economics piece describes the financial pressure that makes cutting materials a logical response to margin compression. The treatment timeline biology piece describes the time pressure that makes proper prosthetic finishing impossible. This piece describes where those pressures end up: in the material choice and the laboratory specification, invisible to the patient at the appointment, visible on a radiograph or in a debonded crown a few years later.

What would change this assessment

The material tier problem would resolve if: Turkish dental tourism platforms published, voluntarily and verifiably, the implant systems and crown materials used across their patient cohorts, with five-year follow-up on crown survival and implant integration. If the survival rates in that data were comparable to the published benchmarks from named-system clinical trials, the inference that cheaper materials are being used in the price-sensitive market segment would need to be revised.

The current state is that no such data is published. The British Dental Association’s 2022 member survey found 86% of UK dentists treating post-overseas complications, with remediation costs of £500 to over £5,000 in a significant proportion. The pattern is consistent with a mix of treatment-planning failures, timeline failures, and material failures. Disaggregating them would require the kind of prospective documentation the market does not currently produce.

For the crown material comparison that sits directly underneath the tier question (when zirconia is correctly indicated versus porcelain-fused-to-metal, what the survival evidence says about each, and what patient factors determine the better choice), see the zirconia-versus-PFM review. For the bone grafting material tier question that applies at the surgical rather than the prosthetic stage, see the bone grafting materials piece. For the peri-implantitis risk that low-documentation implant systems contribute to, see the peri-implantitis cascade piece. For what happens legally when materials fail and the patient has no documentation, see the cross-border liability review. For the broader clinical picture of the Turkey teeth failure pattern, see the Turkey teeth honest account. For the supply-chain version of the material-tier problem, where the brand name on the box is the thing the counterfeit copies, see the Osstem counterfeit-implant alert.